Literature DB >> 2021429

The impact of continuous electrophysiological monitoring on preservation of the facial nerve during acoustic tumour surgery.

D A Jellinek1, L C Tan, L Symon.   

Abstract

Continuous electromyographic (EMG) activity and responses to electrical stimulation of the facial nerve were monitored intraoperatively in 35 patients undergoing primary removal of acoustic neuroma. The rate of anatomical and immediate functional preservation of the facial nerve of these patients was compared with a matched population where a facial nerve stimulator and monitoring of facial muscle contraction by the anaesthetist only was employed. Overall, 94% (n = 33) of facial nerves were preserved anatomically in patients with continuous EMG monitoring, compared with 64% (n = 89) of patients (n = 139) without continuous monitoring. Amongst the 33 cases with anatomical facial nerve preservation, 64% (n = 21) had immediate functional preservation. Immediate functional preservation was only achieved in 39% (n = 35) of anatomically preserved facial nerves (n = 89) where conventional monitoring was used.

Entities:  

Mesh:

Year:  1991        PMID: 2021429     DOI: 10.3109/02688699108998442

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  4 in total

1.  Facial Nerve Monitoring under Neuromuscular Blockade.

Authors:  T O Hester; A Hasan; F McDonnell; J Valentino; R Jones
Journal:  Skull Base Surg       Date:  1995

2.  Intraoperative monitoring of motor cranial nerves in skull base surgery.

Authors:  J Maurer; H Pelster; R G Amedee; W J Mann
Journal:  Skull Base Surg       Date:  1995

Review 3.  [Cerebellopontine angle surgery. Part 2: Specific remarks].

Authors:  B Schaller
Journal:  HNO       Date:  2003-03-28       Impact factor: 1.284

4.  Intraoperative monitoring of lower cranial nerves in skull base surgery: technical report and review of 123 monitored cases.

Authors:  Cahide Topsakal; Ossama Al-Mefty; Ketan R Bulsara; Veronica S Williford
Journal:  Neurosurg Rev       Date:  2007-10-24       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.